APA

Molina J., Clumeck N., Orkin C., Rimsky L. T., Vanveggel S. & Stevens M. (20140610). Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials. : HIV medicine.

Chicago

Molina J-M, Clumeck N, Orkin C, Rimsky L T, Vanveggel S and Stevens M. 20140610. Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials. : HIV medicine.

Harvard

Molina J., Clumeck N., Orkin C., Rimsky L. T., Vanveggel S. and Stevens M. (20140610). Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials. : HIV medicine.

MLA

Molina J-M, Clumeck N, Orkin C, Rimsky L T, Vanveggel S and Stevens M. Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials. : HIV medicine. 20140610.